Joanna Hellmuth1, Benedetta Milanini, Victor Valcour. 1. aDepartment of Neurology, University of California, San Francisco, California, USA bInstitute of Clinical Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy cDivision of Geriatric Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this study is to summarize recent advances in ageing and neuroAIDS by reviewing relevant articles from the preceding 18 months from PubMed and PsycINFO databases. RECENT FINDINGS: The success of combination antiretroviral therapy (cART) has led to ageing of the HIV-infected population, which in turn contributes to the prevalence of HIV-associated neurocognitive disorder (HAND). Biomedical advances continue to clarify the pathophysiology of HAND despite effective cART, including chronic inflammatory and neurovascular causes. In recent months, associations between HAND and nonneurological medical diseases have been identified, as well as linkage to neuroimaging in those ageing with HIV. Developing effective screening tools to detect impairment remains an important scientific gap, although promoting factors associated with successful cognitive ageing is emerging as a possible means of enhancing quality of life. SUMMARY: A greater understanding of HAND pathophysiology among treated individuals with suppressed virus will aid in explaining the high prevalence of HAND despite effective cART and allow for development of novel targeted interventions. Neuroimaging and other biomarkers show promise in discerning HAND from age-associated cognitive disorders. Effective screening tools remain critically needed. Together, this work will inform promising strategies needed to address issues pertinent to an expanding group of older patients living with HIV.
PURPOSE OF REVIEW: The purpose of this study is to summarize recent advances in ageing and neuroAIDS by reviewing relevant articles from the preceding 18 months from PubMed and PsycINFO databases. RECENT FINDINGS: The success of combination antiretroviral therapy (cART) has led to ageing of the HIV-infected population, which in turn contributes to the prevalence of HIV-associated neurocognitive disorder (HAND). Biomedical advances continue to clarify the pathophysiology of HAND despite effective cART, including chronic inflammatory and neurovascular causes. In recent months, associations between HAND and nonneurological medical diseases have been identified, as well as linkage to neuroimaging in those ageing with HIV. Developing effective screening tools to detect impairment remains an important scientific gap, although promoting factors associated with successful cognitive ageing is emerging as a possible means of enhancing quality of life. SUMMARY: A greater understanding of HAND pathophysiology among treated individuals with suppressed virus will aid in explaining the high prevalence of HAND despite effective cART and allow for development of novel targeted interventions. Neuroimaging and other biomarkers show promise in discerning HAND from age-associated cognitive disorders. Effective screening tools remain critically needed. Together, this work will inform promising strategies needed to address issues pertinent to an expanding group of older patients living with HIV.
Authors: Beau K Nakamoto; Cecilia M Shikuma; Debra Ogata-Arakaki; Tracie Umaki; Edward A Neuwelt; Bruce T Shiramizu; Dominic C Chow; Nisha I Parikh; Kalpana J Kallianpur; Bronwyn E Hamilton Journal: J Neurovirol Date: 2013-10-16 Impact factor: 2.643
Authors: Neda Jahanshad; Victor G Valcour; Talia M Nir; Omid Kohannim; Edgar Busovaca; Krista Nicolas; Paul M Thompson Journal: Brain Connect Date: 2012
Authors: J M Foley; A L Gooding; A D Thames; M L Ettenhofer; M S Kim; S A Castellon; T D Marcotte; J R Sadek; R K Heaton; W G van Gorp; C H Hinkin Journal: Am J Alzheimers Dis Other Demen Date: 2013-01-11 Impact factor: 2.035
Authors: Edgar Turner Overton; Tej D Azad; Neva Parker; Debra Demarco Shaw; Judy Frain; Teresa Spitz; Elizabeth Westerhaus; Robert Paul; David B Clifford; Beau M Ances Journal: J Neurovirol Date: 2013-01-24 Impact factor: 2.643
Authors: Talia M Nir; Neda Jahanshad; Edgar Busovaca; Lauren Wendelken; Krista Nicolas; Paul M Thompson; Victor G Valcour Journal: Hum Brain Mapp Date: 2013-01-30 Impact factor: 5.038
Authors: Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck Journal: AIDS Date: 2019-02-01 Impact factor: 4.177
Authors: L Ene; T D Marcotte; A Umlauf; C Grancea; A Temereanca; A Bharti; C L Achim; S Letendre; S M Ruta Journal: J Neuroimmunol Date: 2016-08-04 Impact factor: 3.478
Authors: Joanne K Marcario; Gurudutt Pendyala; Mariam Riazi; Kandace Fleming; Janet Marquis; Shannon Callen; Steven J Lisco; Stephen C Fowler; Paul D Cheney; Shilpa J Buch Journal: J Neuroimmune Pharmacol Date: 2016-04-02 Impact factor: 4.147